XML 45 R23.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Equity
 12 Months Ended
Dec. 31, 2022
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]  
Stockholders' Equity Stockholders' Equity
    The following information should be read in conjunction with the Consolidated Statement of Stockholders' Equity (Deficit).
    Common Stock Repurchases
On July 31, 2019, the Company announced that its Board of Directors approved the repurchase of up to $100.0 million of its common stock in open market purchases, including under Rule 10b5-1 and/or Rule 10b-18 plans. On November 4, 2021, the Company announced that its Board of Directors approved the repurchase of an additional $150.0 million of its common stock under this program. The stock repurchase program does not have an expiration date.
The Company repurchased 6,662,421 shares of its common stock for $60.0 million in 2022, 4,658,544 shares of its common stock for $50.0 million in 2021 and 3,328,574 shares of its common stock for $30.1 million in 2020, under the stock repurchase program. The amount and timing of repurchases are subject to a variety of factors including liquidity, stock price, applicable legal requirements, other business objectives and market conditions.
As of December 31, 2022, approximately $99.0 million remained available for stock repurchases under this authorization.
Dividends
    The Company paid quarterly dividends of $0.085 through the first quarter of 2020. Effective in the second quarter of 2020, the quarterly dividend was reduced to $0.01 per share.
Accumulated other comprehensive loss
The balance in our AOCL is set forth in the following table:
 
December 31, 2022
December 31, 2021
 (Dollars in thousands)
Foreign currency translation adjustments, net of tax$(29,354)$(22,330)
Commodities, interest rate and foreign currency derivatives, net of tax21,284 14,886 
Total AOCL$(8,070)$(7,444)